Clinical Trial Detail

NCT ID NCT03265080
Title Expressing Personalized Tumor Antigens Study
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Advaxis, Inc.
Indications

head and neck squamous cell carcinoma

colorectal cancer

lung non-small cell carcinoma

Therapies

ADXS-NEO

Age Groups: senior adult

No variant requirements are available.